Case A 13-year-old boy is admitted to hospital for treatment of an asthma attack. He reports daily symptoms of wheeze, cough and breathlessness which interfere with school and sleep despite being on ...

Cite this: Assessment of the Acceptability of a New Salbutamol Multidose Dry Powder Inhaler (DPI) in Patients with Asthma - Medscape - Mar 01, 2000.

Lupin Limited partners with Sino Universal Pharmaceuticals. They will commercialize Tiotropium dry powder inhaler in China. This inhaler treats Chronic Obstructive Pulmonary Disease. Sino Universal ...

NEW DELHI, June 16: Pharma major Lupin Ltd on Monday said it has signed a license and supply agreement with China’s Sino Universal Pharmaceuticals for the commercialisation of Tiotropium dry powder ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious ...

Dr. Haller is the Chair for MannKind’s Phase 3 INHALE-1 study of Afrezza (insulin human) Inhalation Powder in children and adolescents (aged 4-17 years of age).

My 38-year-old daughter was recently told by her dentist she could lose her tooth due to her inhalers prescribed for her life-long asthma. If she needs dental bone grafts, would the NHS pay?